1. A Survey of Methodologies for Assessing Mast Cell Density and Activation in Patients with Functional Abdominal Pain Disorders
   Hunter Friesen et al, 2021, Gastrointestinal Disorders CrossRef
2. Colonic immune cells in irritable bowel syndrome: A systematic review and meta‐analysis
   M. Bashashati et al, 2018, Neurogastroenterology & Motility CrossRef
3. Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease - organic disease or diseased organ?
   W. Kruis, 2013, Alimentary Pharmacology & Therapeutics CrossRef
4. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review
   Grace Burns et al, 2019, American Journal of Gastroenterology CrossRef
5. Mast Cell Disorders of the Gastrointestinal Tract
   Nicole C. Panarelli, 2023, Surgical Pathology Clinics CrossRef
6. Recent developments in the pathophysiology of irritable bowel syndrome
   Magdy El-Salhy, 2015, World Journal of Gastroenterology CrossRef
7. Treatment with novel AP-1 and NF-κB inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis
   MAGDY EL-SALHY et al, 2016, International Journal of Molecular Medicine CrossRef
8. Colonic Mucosal Immune Activity in Irritable Bowel Syndrome: Comparison with Healthy Controls and Patients with Ulcerative Colitis
   Ji Yong Ahn et al, 2014, Digestive Diseases and Sciences CrossRef
9. Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
   Ivana Plavšić et al, 2015, Gastroenterology Research and Practice CrossRef
10. Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome
    Sutheera Ratanasirintrawoot et al, 2016, Journal of Neurogastroenterology and Motility CrossRef
11. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment
    Magdy El-Salhy et al, 2014, Expert Review of Gastroenterology & Hepatology CrossRef
12. The Flavonoid Kurarinone Regulates Macrophage Functions via Aryl Hydrocarbon Receptor and Alleviates Intestinal Inflammation in Irritable Bowel Syndrome
    Xiang Xu et al, 2021, Journal of Inflammation Research CrossRef
13. Recent advances in the diagnosis of irritable bowel syndrome
    Magdy El-Salhy, 2015, Expert Review of Gastroenterology & Hepatology CrossRef
14. Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines
    Ceren Cıralı et al, 2018, World Journal of Pediatrics CrossRef
15. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators
    Juan J Martin‐Viñas et al, 2016, Journal of Digestive Diseases CrossRef
16. What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?
    Nicole C. Panarelli et al, 2023, Modern Pathology CrossRef
17. Human Leukocyte Antigen (HLA) Haplotype Does Not Influence the Inflammatory Pattern of Duodenal Lymphocytosis Linked to Irritable Bowel Syndrome
    Giuseppe Losurdo et al, 2020, Medicina CrossRef
18. Adenosine 2A receptor contributes to the facilitation of post-infectious irritable bowel syndrome by γδ T cellsviathe PKA/CREB/NF-κB signaling pathway
    Li-Wei Dong et al, 2023, World Journal of Gastroenterology CrossRef
19. Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)
    Tarek Mazzawi et al, 2017, International Journal of Molecular Medicine CrossRef
20. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome
    T Mazzawi et al, 2016, European Journal of Clinical Nutrition CrossRef